DailyIQ
|
Last updatedUpdating…

APGE·Apogee Therapeutics Inc.

$134.79
+0.04 (+0.03%)
Pre-Market
High
$134.81
Open
$134.80
Market Cap
10.18B
52W High
$134.88
Low
$134.77
P. Close
$134.79
P/E
-
52W Low
$35.39
Fwd P/E
-25.75
DailyIQ Est.
-
Inst. Ownership
-
Short Interest
5.58%
Technical Score (1D)
82
BUY
News Sentiment
-
NO DATA
BTIG has just downgraded Apogee Therapeutics from a Buy to a Neutral rating, citing a revised mean price target of $132.44. The downgrade signals a reassessment of the company’s valuation relative to its peers, implying that analysts now view the upside potential as more limited. This shift may dampen short‑term enthusiasm for the stock as investors recalibrate expectations for near‑term performance. The move underscores the importance of upcoming earnings releases, which will provide fresh data on revenue growth and cost structure. In addition, the company’s pipeline status—particularly the progress of its lead candidates—will be closely monitored for any signs of accelerated development or setbacks. Regulatory approvals remain a critical watch item, as any delays or denials could further erode investor confidence. Market participants should also keep an eye on any new clinical trial results that could alter the therapeutic landscape for Apogee’s indications. Finally, broader market sentiment toward biotech valuations will influence how quickly the Neutral rating is absorbed, so traders should watch for any shifts in sector-wide risk appetite.

EPS

EstBeatMiss
$-1.16$-1.10$-1.05$-0.99$-0.94Q2'25Q3'26
QtrEstActual+/−
Q3'26$-0.96 - -
Q2'25$-1.05$-1.13-7.9%

Revenue

EstBeatMiss
$-0.15$-0.075$0$0.075$0.15Q3'26
QtrEstActual+/−
Q3'26$0 - -
Q2'25 - - -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

APGE Stock Snapshot

APGE is currently trading at $134.77, giving Apogee Therapeutics Inc. a market cap of 10.18B. Today's range spans $134.77–$134.81, with shares opening at $134.80 and moving down $0.02 (0.0%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY).

Over the past year APGE has traded between $35.39 and $134.88 - the current price is +280.8% off the 52-week low and -0.1% from the high.

What APGE has right now - BUY signal, 82/100 technical score, neutral sentiment at -/100, price $134.77 (near 52-week highs) - is the profile that shows up in screens looking for the broader market growth stories with technical confirmation. At 10.18B in capitalization, the risk/reward of a setup like this is often better than in mega-cap peers where the same signal translates to a smaller percentage move. Range: $35.39–$134.88.

The combination of a BUY signal (82/100) and neutral news sentiment (-/100) puts APGE on the screens of active managers who run quality-momentum overlays, a cohort that can build meaningful positions at 10.18B in the broader market market cap without immediately moving the stock. At $134.77 (near 52-week highs in the $35.39–$134.88 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles